Privia Health Group (PRVA) is back in focus after reporting second quarter 2026 earnings, raising its full year revenue guidance to the top of its prior range, and expanding its footprint and AI initiatives.

Despite the raised 2026 revenue guidance and progress on AI initiatives, Privia Health Group’s short term momentum has cooled, with a 30 day share price return down 22.37%, while the 1 year total shareholder return is up 5.07%.

If the AI story in healthcare interests you, it can be worth widening your watchlist beyond a single stock by reviewing our screener of 44 healthcare AI stocks.

Privia Health Group now trades at a steep discount to both analyst targets and some intrinsic value estimates after that sharp pullback. Is the market rightly cautious about execution risk, or is it overlooking the earnings and guidance picture?

Most Popular Narrative: 30.7% Undervalued

The most followed narrative pegs Privia Health Group’s fair value at $31.42, well above the last close at $21.76, and ties that gap to long term revenue and earnings projections.

Continued investment in proprietary technology and AI-driven workflow automation increases operational efficiency, leading to reduced administrative costs and improved provider productivity, this is already contributing to rising EBITDA margins and is expected to further enhance net margins over time.

Want to see what sits behind that confidence in Privia Health Group? The narrative leans heavily on compounding revenue growth, rising margins and a richer earnings mix over time.

Result: Fair Value of $31.42 (UNDERVALUED)

However, there is still clear risk that tighter payer contracts and rising healthcare labor costs could pressure Privia Health Group’s margins and weaken the bullish narrative.

Another View on Privia Health Group’s Valuation

The popular narrative argues Privia Health Group is about 30.7% undervalued, yet the current P/E ratio of 98.8x already sits far above the US Healthcare industry at 24.8x and peers at 25.7x, as well as the fair ratio of 32.2x. This raises the question of whether the market is already paying upfront for a lot of future growth.

Next Steps

If this mix of optimism and caution around Privia Health Group leaves you undecided, take a closer look at the details and move quickly to shape your own stance. Start with the factors investors already highlight as potential positives by reviewing the 4 key rewards.

Looking for more investment ideas beyond Privia Health Group?

Do not stop with Privia Health Group. Broaden your options with fresh stock ideas so you are not relying on a single company or theme.

• Spot potential value opportunities early by reviewing our list of 51 high quality undervalued stocks before other investors start paying attention.
• Strengthen the quality of your portfolio by focusing on companies in the solid balance sheet and fundamentals stocks screener (49 results) that aim to keep financial risk in check.
• Get ahead of the crowd by scanning the screener containing 18 high quality undiscovered gems that might not yet be widely followed by the market.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.